Recieve emails about upcoming NOVA programs and related content, as well as featured reporting about current events through a science lens.
For thousands of years, cannabis has been used to treat everything from pain to indigestion.
Now, it is finally making its pharmaceutical debut, potentially opening the door for further marijuana-based treatments.
On Monday, the Food and Drug Administration announced the approval of Epidiolex, a cannabidiol (CBD) solution, to treat seizures in two rare forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. CBD is a member of the cannabinoid family, a group of chemicals produced by marijuana and other cannabis plants. Epidiolex is the first cannabis-based drug ever approved by the FDA.
The FDA approval was nearly guaranteed after a panel unanimously